Industry principles for enhancing diversity in clinical trials call for use of digital data collection tools and flexible scheduling of study site visits to reduce barriers to enrollment, as well as greater involvement of under represented communities in the trial design planning process and recruitment of investigators with diverse ethnic and racial backgrounds.

Making clinical trial participation less burdensome through the use of digital data collection tools and flexible scheduling is part of the Pharmaceutical Research and Manufacturers of America’s strategy for enhancing study diversity.